N899 300 (Nizatidine 300 mg)

Pill imprint N899 300 has been identified as Nizatidine 300 mg.

Nizatidine is used in the treatment of gerd; erosive esophagitis; indigestion; duodenal ulcer prophylaxis; stomach ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Nizatidine

Imprint:

N899 300

Strength:

300 mg

Color:

Beige

Size:

19.00 mm

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

H2 antagonists

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Teva Pharmaceuticals USA

National Drug Code (NDC):

00093-1066

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.